<DOC>
	<DOCNO>NCT01393093</DOCNO>
	<brief_summary>The purpose study evaluate effect Transcatheter Arterial Chemoembolization ( TACE ) KMG microsphere treat advance-stage Hepatocellular Carinoma ( HCC ) .</brief_summary>
	<brief_title>Transcatheter Arterial Chemoembolization With KMG Microsphere Treating Advance-stage Hepatocellular Carinomas</brief_title>
	<detailed_description>This prospective , multicentre , random , control clinical trial Transcatheter Arterial Chemoembolization ( TACE ) KMG Microsphere Treating Advance-stage Hepatocellular Carinomas .</detailed_description>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>1 . Hepatocellular Carinomas diagnosis pathology cytology consistent China 2001 guideline Clinical Diagnosis Hepatocellular Carinomas 2. clinical stage（The Barcelona Liver Clinic stag system , BCLC B C ) ，or receive surgical intervention 3. liver function : ChildPugh A、B 4 . PST 0—1（Eastern Cooperative Oncology Group Performance Score , ECOG） 5 . Lifespan≥6 month 6 . First time receive treatment 7 . Can accept follow 8. informed consent get 9. number lesion ≤ 5 1. pregnant lactation woman 2. emotional disturbance 3. serious heart , lung disfunction serious diabetes mellitus 4. serious reactiveness infection ; （exp : type B C hepatitis） 5. liver function : ChildPugh Score C 6. thrombocyte＜6×109/L 7. diffuse HCC 8. widespread metastasis 9. serious atherosclerosis 10. acquire immunodeficiency syndrome ; AIDS 11. thrombosis thrombosis event 6 month 12. renal inadequacy need hemodialysis peritoneal dialysis 13. tumor except basal cell carcinoma carcinoma situ cervix 14. serious alimentary tract hemorrhage 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>HCC</keyword>
	<keyword>TACE</keyword>
</DOC>